Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients

NCT06665815 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT06665815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06665815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2024
Completion date
February 15, 2028
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoantibodies screening, type 1 diabetes